A significant discovery in cancer investigation is arising with the use of mini-antibodies to re-engage damaged p53. This essential malignant suppressor protein is frequently inactivated in several kinds of https://hubwebsites.com/story23500219/mini-antibodies-reactivate-p53-new-potential-approach-for-malignant-management